Marijuana for medicine is significantly benefiting the state of Mississippi. In its inaugural year, the Medical Cannabis Program has generated millions in revenue and sales tax, attracting over 32,000 registered patients, including Mike Watkins.
Watkins, one of the first individuals to purchase medical cannabis soon after its legalization, believes it has revitalized his life. He has experienced improved functioning without excessive medication, which was a challenge during his treatment for PTSD and a traumatic brain injury from his service in Iraq as a combat medic.
“Pharmaceuticals were never just quite the answer for me,” Watkins shared. “They always led to something else. For me, cannabis was a pathway away from those pharmaceutical drugs.” He credits medical marijuana with enhancing his role as a husband and father. Watkins no longer relies on prescription medications, a sentiment echoed by many patients seeking to reduce their pharmaceutical dependence.
Dr. Fred Kency, a board-certified emergency physician, has certified approximately 1,000 patients for medical cannabis in various emergency rooms throughout the state. He noted that many patients have experienced a substantial improvement in their quality of life, particularly those who previously depended on addictive opioids for conditions like cancer, HIV, or PTSD. “We can truly see the positive impact it’s making in our patients,” Kency remarked.
Economic Impact and Legislative Developments
According to State Health Officer Dr. Dan Edney, the priority remains on patients finding relief from debilitating conditions. The Medical Cannabis Program in Mississippi has amassed over $44 million in retail sales within the past year, alongside $8 million in application and licensing fees and more than $2 million in tax revenue. Currently, there are nearly 400 licensed establishments, including dispensaries, and approximately 3,000 individuals now employed in the medical marijuana sector.
Some advocates, like Angie Calhoun from the Mississippi Cannabis Patients Alliance, are urging legislation to expand the list of qualifying conditions to include anxiety and insomnia, highlighting the importance of adequate sleep for overall functioning. Calhoun also suggests that lawmakers should consider allowing monthly prescriptions rather than weekly, and establish more accessible methods for patients to retrieve their medications, such as drive-thru services.
The Patients Alliance is advocating for a $5 million investment in research and education to further explore the benefits of medical cannabis in Mississippi.
